Related Experiment Video
Updated: Mar 21, 2026

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
Published on: June 26, 2018
Recent developments of C-4 substituted coumarin derivatives as anticancer agents
Jyoti Dandriyal1, Ramit Singla1, Manvendra Kumar1
1Centre for Pharmaceutical Sciences and Natural Products, School of Basic and Applied Sciences, Central University of Punjab, Bathinda, 151 001, India.
Researchers are developing novel coumarin derivatives as potent anticancer agents, aiming to overcome limitations like multidrug resistance (MDR) and side effects associated with current cancer therapies.
Area of Science:
- Medicinal Chemistry
- Organic Synthesis
- Pharmacology
Background:
- Cancer remains a leading global cause of mortality.
- Existing cancer drugs often exhibit significant side effects and multidrug resistance (MDR).
- There is a critical need for novel anticancer agents with improved efficacy and safety profiles.
Purpose of the Study:
- To review synthetic strategies for C-4 substituted coumarin derivatives as potential anticancer agents.
- To explore the mechanisms of action and structure-activity relationships (SAR) of these coumarin derivatives.
- To identify promising coumarin-based compounds for overcoming MDR and reducing side effects.
Main Methods:
- Review of synthetic methodologies for preparing C-4 substituted coumarin derivatives.
- Analysis of reported anticancer activities and mechanisms of action.
- Discussion of structure-activity relationships (SAR) for optimized anticancer potency.
Main Results:
- Coumarin derivatives demonstrate broad-spectrum pharmacological activities, including anticancer effects.
- Specific substitution patterns on the coumarin nucleus significantly influence anticancer potency and mechanism.
- C-4 substituted coumarins show promise in reversing multidrug resistance and minimizing side effects.
Conclusions:
- Coumarin derivatives represent a valuable scaffold for developing novel anticancer drugs.
- Targeted C-4 substitution and understanding SAR are crucial for designing effective anticancer agents.
- These compounds offer a promising avenue for overcoming current therapeutic challenges in cancer treatment.
Related Concept Videos
Inhibition of Cdk Activity
Targeted Cancer Therapies
There are several types of targeted therapies against...
Drugs that Stabilize Microtubules
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
Drugs that Destabilize Microtubules

